Ajanta Pharma Ltd
NSE:AJANTPHARM
Ajanta Pharma Ltd
NSE:AJANTPHARM
Price:
2 890.3
INR
-0.24%
Market Closed
Market Cap:
₹361.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ajanta Pharma Ltd
NSE:AJANTPHARM
|
IN |
|
Superloop Ltd
ASX:SLC
|
AU |
|
MacroGenics Inc
NASDAQ:MGNX
|
US |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
US |
|
W
|
Winpac Inc
KOSDAQ:097800
|
KR |
|
Lvji Technology Holdings Inc
HKEX:1745
|
CN |
|
S
|
Steep Hill Inc
CNSX:STPH
|
CA |
|
Amoeba SA
PAR:ALMIB
|
FR |
|
Ambarella Inc
NASDAQ:AMBA
|
US |
Multiples-Based Value
The Multiples-Based Value of one
AJANTPHARM
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 2 890.3 INR,
Ajanta Pharma Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AJANTPHARM Multiples-Based Value
LOCKED
Multiples Across Competitors
AJANTPHARM Competitors Multiples
Ajanta Pharma Ltd Competitors
Ajanta Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Ajanta Pharma Ltd
NSE:AJANTPHARM
|
362B INR | 6.9 | 35.5 | 24.8 | 28 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.7 | 16.4 | 23.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR | 2.7 | 15.2 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
